PUBLISHER: The Business Research Company | PRODUCT CODE: 1945564
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945564
A medical linear accelerator (LINAC) is a radiation therapy device that delivers high-energy X-rays or electrons to treat cancer, using microwave technology to accelerate electrons and create precisely targeted radiation that destroys tumors while minimizing damage to nearby healthy tissue.
The main categories of medical linear accelerators include low-energy and high-energy systems. Low-energy linear accelerators are primarily used to treat superficial tumors and cancers located close to the body surface. These systems generate lower-energy X-rays, making them suitable for targeting tumors near the skin or in shallow tissues. The products are classified into dedicated linear accelerators and non-dedicated linear accelerators for treatment modalities such as intensity-modulated radiation therapy, volumetric modulated arc therapy (VMAT), image-guided radiation therapy, stereotactic radiosurgery, and stereotactic body radiotherapy. The end users include hospitals, clinics, and research centers.
Tariffs are impacting the medical linear accelerator market by increasing costs for imported precision components, high-energy linac systems, and related software solutions. Segments such as high-energy proton therapy linacs and stereotactic radiotherapy systems are most affected, particularly in regions like Asia-Pacific including China and India, which serve as major manufacturing and assembly hubs. This has led to higher procurement costs and project delays. Positively, tariffs are encouraging local manufacturing, component innovation, and increased investment in domestic production to reduce dependency on imports.
The medical linear accelerator market research report is one of a series of new reports from The Business Research Company that provides medical linear accelerator market statistics, including medical linear accelerator industry global market size, regional shares, competitors with a medical linear accelerator market share, detailed medical linear accelerator market segments, market trends and opportunities, and any further data you may need to thrive in the medical linear accelerator industry. This medical linear accelerator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical linear accelerator market size has grown strongly in recent years. It will grow from $4 billion in 2025 to $4.35 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to limited access to advanced radiotherapy technologies, reliance on conventional low-energy linacs, growing cancer incidence rates, increasing hospital and clinic infrastructure, adoption of basic image-guided therapy techniques.
The medical linear accelerator market size is expected to see strong growth in the next few years. It will grow to $6 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to development of high-precision linac systems, expansion of stereotactic and proton therapy applications, rising investment in cancer treatment infrastructure, increasing integration of ai and data analytics in radiotherapy, growth of research centers for oncology and radiation therapy. Major trends in the forecast period include rising adoption of advanced radiation therapy techniques, increasing demand for high-energy linear accelerators, expansion of dedicated linear accelerator installations, growing focus on pediatric and skin cancer treatments, integration of image-guided and stereotactic therapies.
The increasing burden of cancer is increasingly supporting the expansion of the medical linear accelerator market going forward. The demand for cancer treatment continues to rise due to the growing number of cancer cases worldwide, influenced by aging populations, lifestyle changes, and environmental factors, which necessitate advanced and accessible treatment solutions. Medical linear accelerators are widely used in oncology to deliver precise, high-energy radiation beams that target cancer cells while minimizing damage to surrounding healthy tissue, making them essential for controlled and effective radiation therapy. For example, in January 2024, according to the American Cancer Society, a US-based organization, approximately 297,790 new cases of invasive breast cancer were diagnosed among women in 2023. Consequently, the growing burden of cancer is reinforcing demand for medical linear accelerators.
Leading companies operating in the medical linear accelerator market are concentrating on developing and optimizing treatment planning using artificial intelligence and machine learning algorithms, including AI-enhanced imaging, to improve treatment precision, patient outcomes, and operational efficiency. AI-enhanced imaging improves treatment accuracy by generating clearer and more precise images, enabling better tumor detection, localization, and personalized treatment planning. For example, in May 2024, Elekta, a Sweden-based neuroscience company, launched Evo, a CT-Linac equipped with advanced AI-enhanced imaging capabilities. This system supports both offline and online adaptive radiation therapy alongside improved image-guided radiation therapy. Evo allows clinicians to select optimal treatment techniques tailored to individual patient needs, while its adaptive capabilities reduce uncertainty and minimize radiation exposure to surrounding organs. The platform also integrates advanced anatomy-specific algorithms and Iris imaging technology to enhance visualization and automation. In addition, Elekta expanded its software portfolio with Elekta ONE Planning powered by MIM, enabling distributed treatment planning, faster dose calculations, and AI-driven contouring and planning automation.
In August 2023, BEBIG Medical GmbH, a Germany-based provider of radiation therapy products for cancer treatment, partnered with SHINVA for its radiation therapy business. This strategic collaboration combines the strengths of BEBIG Medical and SHINVA to deliver reliable hardware and user-friendly operating systems, making linear accelerator technology more accessible worldwide and supporting affordable healthcare for a broader population. SHINVA is a China-based manufacturer of medical equipment.
Major companies operating in the medical linear accelerator market are Mitsubishi Heavy Industries Ltd., Toshiba Corporation, Siemens Healthineers, Elekta AB, Hitachi High-Tech Corporation, Shinva Medical Instrument Co. Ltd., Accuray Incorporated, Brainlab AG, Mevion Medical Solutions, ViewRay Inc., PTW Freiburg GmbH, CIVCO Medical Solutions, C-RAD, Panacea Medical Technologies Pvt. Ltd., Mirada Medical, Varian Medical Systems, IBA Worldwide, RefleXion Medical, Best Theratronics Ltd., Advanced Oncotherapy plc, Sumitomo Heavy Industries Ltd., Theragenics Corporation, Xstrahl Limited.
North America was the largest region in the medical linear accelerator market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market. The regions covered in the medical linear accelerator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical linear accelerator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical linear accelerator market consists of sales of advanced LINAC system, compact and fast medical linear accelerator system, and robotic medical linear accelerator system. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Linear Accelerator Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical linear accelerator market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical linear accelerator ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical linear accelerator market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.